Glioblastoma: Current Status, Emerging Targets, and Recent Advances-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glioblastoma: Current Status, Emerging Targets, and Recent Advances

Published:2022-07-05 Issue:13 Volume:65 Page:8596-8685
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Thakur Amandeep¹,Faujdar Chetna²,Sharma Ram¹,Sharma Sachin¹,Malik Basant³,Nepali Kunal¹^ORCID,Liou Jing Ping¹^ORCID

Affiliation:

1. School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan

2. Department of Biotechnology, Jaypee Institute of Information Technology, Noida 201307, India

3. Department of Sterile Product Development, Research and Development-Unit 2, Jubiliant Generics Ltd., Noida 201301, India

Funder

Ministry of Science and Technology, Taiwan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01946

Reference588 articles.

1. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme

2. Malignant Gliomas in Adults

3. Glioblastoma Multiforme Therapy and Mechanisms of Resistance

4. Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions

5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies;Foods;2024-08-26

2. Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells;IUBMB Life;2024-08-12

3. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients;Journal of Pharmaceutical and Biomedical Analysis;2024-08

4. Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence;Neuroscience;2024-08

5. Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy;WIREs Nanomedicine and Nanobiotechnology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3